APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neohesperidoside

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neohesperidoside Industry Growth and Trends Forecast to 2032

Report ID 173316750127 December 2025104 pages

Choose your research edition.

Industry ResearchNeohesperidoside Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Neohesperidoside Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Neohesperidoside Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neohesperidoside Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Neohesperidoside Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Neohesperidoside market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neohesperidoside is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neohesperidoside is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neohesperidoside is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neohesperidoside include Biospringer, DowDuPont, BASF SE, FMC Health and Nutrition, Firmenich SA, Edlong Dairy Technologies, CP Kelco, Corbion NV and Chr.Hansen Holding A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neohesperidoside market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neohesperidoside market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neohesperidoside market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neohesperidoside.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neohesperidoside market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neohesperidoside Market by Company

Biospringer

DowDuPont

BASF SE

FMC Health and Nutrition

Firmenich SA

Edlong Dairy Technologies

CP Kelco

Corbion NV

Chr.Hansen Holding A/S

Cargill

Neohesperidoside Segment by Type

Pharmacy Grade

Food Grade

Industrial Grade

Neohesperidoside Segment by Application

Cosmetics

Food

Medicine

Neohesperidoside Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neohesperidoside market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neohesperidoside and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neohesperidoside.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neohesperidoside manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neohesperidoside in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pharmacy Grade Table 2. Major Company of Food Grade Table 3. Major Company of Industrial Grade Table 4. Global Neohesperidoside Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Neohesperidoside Sales by Type (2021-2026) & (t) Table 6. Global Neohesperidoside Sales Market Share in Volume by Type (2021-2026) Table 7. Global Neohesperidoside Sales by Type (2021-2026) & (US$ Million) Table 8. Global Neohesperidoside Sales Market Share in Value by Type (2021-2026) Table 9. Global Neohesperidoside Price by Type (2021-2026) & (USD/t) Table 10. Global Neohesperidoside Sales by Type (2027-2032) & (t) Table 11. Global Neohesperidoside Sales Market Share in Volume by Type (2027-2032) Table 12. Global Neohesperidoside Sales by Type (2027-2032) & (US$ Million) Table 13. Global Neohesperidoside Sales Market Share in Value by Type (2027-2032) Table 14. Global Neohesperidoside Price by Type (2027-2032) & (USD/t) Table 15. North America Neohesperidoside Sales by Type (2021-2026) & (t) Table 16. North America Neohesperidoside Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Neohesperidoside Sales by Type (2021-2026) & (t) Table 18. Europe Neohesperidoside Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Neohesperidoside Sales by Type (2021-2026) & (t) Table 20. Asia-Pacific Neohesperidoside Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Neohesperidoside Sales by Type (2021-2026) & (t) Table 22. Latin America Neohesperidoside Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Neohesperidoside Sales by Type (2021-2026) & (t) Table 24. Middle East and Africa Neohesperidoside Sales by Type (2021-2026) & (US$ Million) Table 25. Neohesperidoside Industry Trends Table 26. Neohesperidoside Industry Drivers Table 27. Neohesperidoside Industry Opportunities and Challenges Table 28. Neohesperidoside Industry Restraints Table 29. Global Neohesperidoside Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Neohesperidoside Revenue Market Share by Company (2021-2026) Table 31. Global Neohesperidoside Sales by Company (2021-2026) & (t) Table 32. Global Neohesperidoside Sales Share by Company (2021-2026) Table 33. Global Neohesperidoside Market Price by Company (2021-2026) & (USD/t) Table 34. Global Neohesperidoside Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Neohesperidoside Major Company Production Sites and Headquarters Table 36. Global Neohesperidoside Company, Product Type & Application Table 37. Global Neohesperidoside Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Neohesperidoside by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Neohesperidoside Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Neohesperidoside Sales by Region (2021-2026) & (t) Table 42. Global Neohesperidoside Sales Market Share in Volume by Region (2021-2026) Table 43. Global Neohesperidoside Sales by Region (2021-2026) & (US$ Million) Table 44. Global Neohesperidoside Sales Market Share in Value by Region (2021-2026) Table 45. Global Neohesperidoside Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 46. Global Neohesperidoside Sales by Region (2027-2032) & (t) Table 47. Global Neohesperidoside Sales Market Share in Volume by Region (2027-2032) Table 48. Global Neohesperidoside Sales by Region (2027-2032) & (US$ Million) Table 49. Global Neohesperidoside Sales Market Share in Value by Region (2027-2032) Table 50. Global Neohesperidoside Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 51. Global Neohesperidoside Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Neohesperidoside Sales by Application (2021-2026) & (t) Table 53. Global Neohesperidoside Sales Market Share in Volume by Application (2021-2026) Table 54. Global Neohesperidoside Sales by Application (2021-2026) & (US$ Million) Table 55. Global Neohesperidoside Sales Market Share in Value by Application (2021-2026) Table 56. Global Neohesperidoside Price by Application (2021-2026) & (USD/t) Table 57. Global Neohesperidoside Sales by Application (2027-2032) & (t) Table 58. Global Neohesperidoside Sales Market Share in Volume by Application (2027-2032) Table 59. Global Neohesperidoside Sales by Application (2027-2032) & (US$ Million) Table 60. Global Neohesperidoside Sales Market Share in Value by Application (2027-2032) Table 61. Global Neohesperidoside Price by Application (2027-2032) & (USD/t) Table 62. North America Neohesperidoside Sales by Application (2021-2026) & (t) Table 63. North America Neohesperidoside Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Neohesperidoside Sales by Application (2021-2026) & (t) Table 65. Europe Neohesperidoside Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Neohesperidoside Sales by Application (2021-2026) & (t) Table 67. Asia-Pacific Neohesperidoside Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Neohesperidoside Sales by Application (2021-2026) & (t) Table 69. Latin America Neohesperidoside Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Neohesperidoside Sales by Application (2021-2026) & (t) Table 71. Middle East and Africa Neohesperidoside Sales by Application (2021-2026) & (US$ Million) Table 72. Biospringer Company Information Table 73. Biospringer Business Overview Table 74. Biospringer Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Biospringer Neohesperidoside Product Portfolio Table 76. Biospringer Recent Development Table 77. DowDuPont Company Information Table 78. DowDuPont Business Overview Table 79. DowDuPont Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. DowDuPont Neohesperidoside Product Portfolio Table 81. DowDuPont Recent Development Table 82. BASF SE Company Information Table 83. BASF SE Business Overview Table 84. BASF SE Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. BASF SE Neohesperidoside Product Portfolio Table 86. BASF SE Recent Development Table 87. FMC Health and Nutrition Company Information Table 88. FMC Health and Nutrition Business Overview Table 89. FMC Health and Nutrition Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. FMC Health and Nutrition Neohesperidoside Product Portfolio Table 91. FMC Health and Nutrition Recent Development Table 92. Firmenich SA Company Information Table 93. Firmenich SA Business Overview Table 94. Firmenich SA Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. Firmenich SA Neohesperidoside Product Portfolio Table 96. Firmenich SA Recent Development Table 97. Edlong Dairy Technologies Company Information Table 98. Edlong Dairy Technologies Business Overview Table 99. Edlong Dairy Technologies Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. Edlong Dairy Technologies Neohesperidoside Product Portfolio Table 101. Edlong Dairy Technologies Recent Development Table 102. CP Kelco Company Information Table 103. CP Kelco Business Overview Table 104. CP Kelco Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. CP Kelco Neohesperidoside Product Portfolio Table 106. CP Kelco Recent Development Table 107. Corbion NV Company Information Table 108. Corbion NV Business Overview Table 109. Corbion NV Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. Corbion NV Neohesperidoside Product Portfolio Table 111. Corbion NV Recent Development Table 112. Chr.Hansen Holding A/S Company Information Table 113. Chr.Hansen Holding A/S Business Overview Table 114. Chr.Hansen Holding A/S Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 115. Chr.Hansen Holding A/S Neohesperidoside Product Portfolio Table 116. Chr.Hansen Holding A/S Recent Development Table 117. Cargill Company Information Table 118. Cargill Business Overview Table 119. Cargill Neohesperidoside Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 120. Cargill Neohesperidoside Product Portfolio Table 121. Cargill Recent Development Table 122. North America Neohesperidoside Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 123. North America Neohesperidoside Sales by Country (2021-2026) & (t) Table 124. North America Neohesperidoside Sales Market Share by Country (2021-2026) Table 125. North America Neohesperidoside Sales Forecast by Country (2027-2032) & (t) Table 126. North America Neohesperidoside Sales Market Share Forecast by Country (2027-2032) Table 127. North America Neohesperidoside Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Neohesperidoside Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Neohesperidoside Market Share by Country (2021-2026) Table 130. North America Neohesperidoside Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Neohesperidoside Market Share Forecast by Country (2027-2032) Table 132. Europe Neohesperidoside Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 133. Europe Neohesperidoside Sales by Country (2021-2026) & (t) Table 134. Europe Neohesperidoside Sales Market Share by Country (2021-2026) Table 135. Europe Neohesperidoside Sales Forecast by Country (2027-2032) & (t) Table 136. Europe Neohesperidoside Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Neohesperidoside Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Neohesperidoside Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Neohesperidoside Market Share by Country (2021-2026) Table 140. Europe Neohesperidoside Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Neohesperidoside Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Neohesperidoside Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Neohesperidoside Sales by Country (2021-2026) & (t) Table 144. Asia-Pacific Neohesperidoside Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Neohesperidoside Sales Forecast by Country (2027-2032) & (t) Table 146. Asia-Pacific Neohesperidoside Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Neohesperidoside Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Neohesperidoside Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Neohesperidoside Market Share by Country (2021-2026) Table 150. Asia-Pacific Neohesperidoside Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Neohesperidoside Market Share Forecast by Country (2027-2032) Table 152. Latin America Neohesperidoside Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 153. Latin America Neohesperidoside Sales by Country (2021-2026) & (t) Table 154. Latin America Neohesperidoside Sales Market Share by Country (2021-2026) Table 155. Latin America Neohesperidoside Sales Forecast by Country (2027-2032) & (t) Table 156. Latin America Neohesperidoside Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Neohesperidoside Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Neohesperidoside Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Neohesperidoside Market Share by Country (2021-2026) Table 160. Latin America Neohesperidoside Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Neohesperidoside Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Neohesperidoside Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Neohesperidoside Sales by Country (2021-2026) & (t) Table 164. Middle East and Africa Neohesperidoside Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Neohesperidoside Sales Forecast by Country (2027-2032) & (t) Table 166. Middle East and Africa Neohesperidoside Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Neohesperidoside Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Neohesperidoside Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Neohesperidoside Market Share by Country (2021-2026) Table 170. Middle East and Africa Neohesperidoside Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Neohesperidoside Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Neohesperidoside Distributors List Table 175. Neohesperidoside Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Neohesperidoside Image Figure 2. Global Neohesperidoside Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neohesperidoside Market Size (2021-2032) & (US$ Million) Figure 4. Global Neohesperidoside Sales (2021-2032) & (t) Figure 5. Pharmacy Grade Image Figure 6. Global Pharmacy Grade Sales YoY Growth (2021-2032) & (t) Figure 7. Food Grade Image Figure 8. Global Food Grade Sales YoY Growth (2021-2032) & (t) Figure 9. Industrial Grade Image Figure 10. Global Industrial Grade Sales YoY Growth (2021-2032) & (t) Figure 11. Global Neohesperidoside Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Neohesperidoside Market Share by Type 2025 VS 2032 Figure 13. North America Neohesperidoside Sales Market Share in Volume by Type in 2025 Figure 14. North America Neohesperidoside Sales Market Share in Value by Type in 2025 Figure 15. Europe Neohesperidoside Sales Market Share in Volume by Type in 2025 Figure 16. Europe Neohesperidoside Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Neohesperidoside Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Neohesperidoside Sales Market Share in Value by Type in 2025 Figure 19. Latin America Neohesperidoside Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Neohesperidoside Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Neohesperidoside Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Neohesperidoside Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Neohesperidoside Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cosmetics Image Figure 26. Global Cosmetics Sales YoY Growth (2021-2032) & (t) Figure 27. Food Image Figure 28. Global Food Sales YoY Growth (2021-2032) & (t) Figure 29. Medicine Image Figure 30. Global Medicine Sales YoY Growth (2021-2032) & (t) Figure 31. Global Neohesperidoside Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Neohesperidoside Market Share by Application 2025 VS 2032 Figure 33. North America Neohesperidoside Sales Market Share in Volume by Application in 2025 Figure 34. North America Neohesperidoside Sales Market Share in Value by Application in 2025 Figure 35. Europe Neohesperidoside Sales Market Share in Volume by Application in 2025 Figure 36. Europe Neohesperidoside Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Neohesperidoside Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Neohesperidoside Sales Market Share in Value by Application in 2025 Figure 39. Latin America Neohesperidoside Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Neohesperidoside Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Neohesperidoside Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Neohesperidoside Sales Market Share in Value by Application in 2025 Figure 43. North America Neohesperidoside Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. North America Neohesperidoside Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Neohesperidoside Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Neohesperidoside Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Neohesperidoside Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Europe Neohesperidoside Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Neohesperidoside Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Neohesperidoside Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Neohesperidoside Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Asia-Pacific Neohesperidoside Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Neohesperidoside Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Neohesperidoside Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Neohesperidoside Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Latin America Neohesperidoside Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Neohesperidoside Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Neohesperidoside Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Neohesperidoside Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 60. Middle East and Africa Neohesperidoside Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Neohesperidoside Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Neohesperidoside Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Neohesperidoside Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Neohesperidoside Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmacy Grade
  • Food Grade
  • Industrial Grade
Applications
  • Cosmetics
  • Food
  • Medicine
Companies covered
  • Biospringer
  • DowDuPont
  • BASF SE
  • FMC Health and Nutrition
  • Firmenich SA
  • Edlong Dairy Technologies
  • CP Kelco
  • Corbion NV
  • Chr.Hansen Holding A/S
  • Cargill

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neohesperidoside Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neohesperidoside Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neohesperidoside Market by Type
  6. 1.3.1 Pharmacy Grade
  7. 1.3.2 Food Grade
  8. 1.3.3 Industrial Grade
  9. 1.4 Global Neohesperidoside Market Size by Type
  10. 1.4.1 Global Neohesperidoside Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Neohesperidoside Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Neohesperidoside Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Neohesperidoside Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Neohesperidoside Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Neohesperidoside Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Neohesperidoside Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Neohesperidoside Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neohesperidoside Industry Trends
  2. 2.2 Neohesperidoside Industry Drivers
  3. 2.3 Neohesperidoside Industry Opportunities and Challenges
  4. 2.4 Neohesperidoside Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neohesperidoside Revenue (2021-2026)
  2. 3.2 Global Top Players by Neohesperidoside Sales (2021-2026)
  3. 3.3 Global Top Players by Neohesperidoside Price (2021-2026)
  4. 3.4 Global Neohesperidoside Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neohesperidoside Major Company Production Sites & Headquarters
  6. 3.6 Global Neohesperidoside Company, Product Type & Application
  7. 3.7 Global Neohesperidoside Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neohesperidoside Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neohesperidoside Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neohesperidoside Tier 1, Tier 2, and Tier 3
4 Neohesperidoside Regional Status and Outlook
  1. 4.1 Global Neohesperidoside Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neohesperidoside Historic Market Size by Region
  3. 4.2.1 Global Neohesperidoside Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neohesperidoside Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neohesperidoside Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neohesperidoside Forecasted Market Size by Region
  7. 4.3.1 Global Neohesperidoside Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neohesperidoside Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neohesperidoside Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neohesperidoside by Application
  1. 5.1 Neohesperidoside Market by Application
  2. 5.1.1 Cosmetics
  3. 5.1.2 Food
  4. 5.1.3 Medicine
  5. 5.2 Global Neohesperidoside Market Size by Application
  6. 5.2.1 Global Neohesperidoside Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Neohesperidoside Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Neohesperidoside Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Neohesperidoside Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Neohesperidoside Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Neohesperidoside Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Neohesperidoside Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Neohesperidoside Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biospringer
  2. 6.1.1 Biospringer Company Information
  3. 6.1.2 Biospringer Business Overview
  4. 6.1.3 Biospringer Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biospringer Neohesperidoside Product Portfolio
  6. 6.1.5 Biospringer Recent Developments
  7. 6.2 DowDuPont
  8. 6.2.1 DowDuPont Company Information
  9. 6.2.2 DowDuPont Business Overview
  10. 6.2.3 DowDuPont Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 DowDuPont Neohesperidoside Product Portfolio
  12. 6.2.5 DowDuPont Recent Developments
  13. 6.3 BASF SE
  14. 6.3.1 BASF SE Company Information
  15. 6.3.2 BASF SE Business Overview
  16. 6.3.3 BASF SE Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BASF SE Neohesperidoside Product Portfolio
  18. 6.3.5 BASF SE Recent Developments
  19. 6.4 FMC Health and Nutrition
  20. 6.4.1 FMC Health and Nutrition Company Information
  21. 6.4.2 FMC Health and Nutrition Business Overview
  22. 6.4.3 FMC Health and Nutrition Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 FMC Health and Nutrition Neohesperidoside Product Portfolio
  24. 6.4.5 FMC Health and Nutrition Recent Developments
  25. 6.5 Firmenich SA
  26. 6.5.1 Firmenich SA Company Information
  27. 6.5.2 Firmenich SA Business Overview
  28. 6.5.3 Firmenich SA Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Firmenich SA Neohesperidoside Product Portfolio
  30. 6.5.5 Firmenich SA Recent Developments
  31. 6.6 Edlong Dairy Technologies
  32. 6.6.1 Edlong Dairy Technologies Company Information
  33. 6.6.2 Edlong Dairy Technologies Business Overview
  34. 6.6.3 Edlong Dairy Technologies Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Edlong Dairy Technologies Neohesperidoside Product Portfolio
  36. 6.6.5 Edlong Dairy Technologies Recent Developments
  37. 6.7 CP Kelco
  38. 6.7.1 CP Kelco Company Information
  39. 6.7.2 CP Kelco Business Overview
  40. 6.7.3 CP Kelco Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CP Kelco Neohesperidoside Product Portfolio
  42. 6.7.5 CP Kelco Recent Developments
  43. 6.8 Corbion NV
  44. 6.8.1 Corbion NV Company Information
  45. 6.8.2 Corbion NV Business Overview
  46. 6.8.3 Corbion NV Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Corbion NV Neohesperidoside Product Portfolio
  48. 6.8.5 Corbion NV Recent Developments
  49. 6.9 Chr.Hansen Holding A/S
  50. 6.9.1 Chr.Hansen Holding A/S Company Information
  51. 6.9.2 Chr.Hansen Holding A/S Business Overview
  52. 6.9.3 Chr.Hansen Holding A/S Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chr.Hansen Holding A/S Neohesperidoside Product Portfolio
  54. 6.9.5 Chr.Hansen Holding A/S Recent Developments
  55. 6.10 Cargill
  56. 6.10.1 Cargill Company Information
  57. 6.10.2 Cargill Business Overview
  58. 6.10.3 Cargill Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cargill Neohesperidoside Product Portfolio
  60. 6.10.5 Cargill Recent Developments
7 North America by Country
  1. 7.1 North America Neohesperidoside Sales by Country
  2. 7.1.1 North America Neohesperidoside Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neohesperidoside Sales by Country (2021-2026)
  4. 7.1.3 North America Neohesperidoside Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neohesperidoside Market Size by Country
  6. 7.2.1 North America Neohesperidoside Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neohesperidoside Market Size by Country (2021-2026)
  8. 7.2.3 North America Neohesperidoside Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neohesperidoside Sales by Country
  2. 8.1.1 Europe Neohesperidoside Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neohesperidoside Sales by Country (2021-2026)
  4. 8.1.3 Europe Neohesperidoside Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neohesperidoside Market Size by Country
  6. 8.2.1 Europe Neohesperidoside Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neohesperidoside Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neohesperidoside Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neohesperidoside Sales by Country
  2. 9.1.1 Asia-Pacific Neohesperidoside Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neohesperidoside Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neohesperidoside Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neohesperidoside Market Size by Country
  6. 9.2.1 Asia-Pacific Neohesperidoside Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neohesperidoside Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neohesperidoside Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neohesperidoside Sales by Country
  2. 10.1.1 South America Neohesperidoside Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neohesperidoside Sales by Country (2021-2026)
  4. 10.1.3 South America Neohesperidoside Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neohesperidoside Market Size by Country
  6. 10.2.1 South America Neohesperidoside Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neohesperidoside Market Size by Country (2021-2026)
  8. 10.2.3 South America Neohesperidoside Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neohesperidoside Sales by Country
  2. 11.1.1 Middle East and Africa Neohesperidoside Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neohesperidoside Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neohesperidoside Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neohesperidoside Market Size by Country
  6. 11.2.1 Middle East and Africa Neohesperidoside Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neohesperidoside Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neohesperidoside Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neohesperidoside Value Chain Analysis
  2. 12.1.1 Neohesperidoside Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neohesperidoside Production Mode & Process
  7. 12.2 Neohesperidoside Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neohesperidoside Distributors
  10. 12.2.3 Neohesperidoside Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst